1. Home
  2. ZCAR vs GLTO Comparison

ZCAR vs GLTO Comparison

Compare ZCAR & GLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZCAR
  • GLTO
  • Stock Information
  • Founded
  • ZCAR 2013
  • GLTO 2011
  • Country
  • ZCAR India
  • GLTO Denmark
  • Employees
  • ZCAR N/A
  • GLTO N/A
  • Industry
  • ZCAR Blank Checks
  • GLTO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZCAR Finance
  • GLTO Health Care
  • Exchange
  • ZCAR Nasdaq
  • GLTO Nasdaq
  • Market Cap
  • ZCAR 8.8M
  • GLTO 6.5M
  • IPO Year
  • ZCAR N/A
  • GLTO 2020
  • Fundamental
  • Price
  • ZCAR $1.20
  • GLTO $4.71
  • Analyst Decision
  • ZCAR
  • GLTO Buy
  • Analyst Count
  • ZCAR 0
  • GLTO 1
  • Target Price
  • ZCAR N/A
  • GLTO $10.00
  • AVG Volume (30 Days)
  • ZCAR 752.6K
  • GLTO 17.6K
  • Earning Date
  • ZCAR 02-14-2025
  • GLTO 03-07-2025
  • Dividend Yield
  • ZCAR N/A
  • GLTO N/A
  • EPS Growth
  • ZCAR N/A
  • GLTO N/A
  • EPS
  • ZCAR 1.91
  • GLTO N/A
  • Revenue
  • ZCAR $9,089,489.00
  • GLTO N/A
  • Revenue This Year
  • ZCAR N/A
  • GLTO N/A
  • Revenue Next Year
  • ZCAR N/A
  • GLTO N/A
  • P/E Ratio
  • ZCAR $0.61
  • GLTO N/A
  • Revenue Growth
  • ZCAR N/A
  • GLTO N/A
  • 52 Week Low
  • ZCAR $1.00
  • GLTO $4.40
  • 52 Week High
  • ZCAR $214.00
  • GLTO $23.50
  • Technical
  • Relative Strength Index (RSI)
  • ZCAR 31.70
  • GLTO 45.14
  • Support Level
  • ZCAR $1.03
  • GLTO $4.70
  • Resistance Level
  • ZCAR $1.95
  • GLTO $5.11
  • Average True Range (ATR)
  • ZCAR 0.17
  • GLTO 0.38
  • MACD
  • ZCAR 0.03
  • GLTO -0.01
  • Stochastic Oscillator
  • ZCAR 7.77
  • GLTO 26.23

About ZCAR Zoomcar Holdings Inc.

Zoomcar Holdings Inc is India's largest marketplace for cars on rent. Zoomcar is a leading emerging-market-focused peer-to-peer car-sharing marketplace, with approximately 21,000 vehicles registered through its platform. The Company derives its revenue principally from short-term self-drive rentals and vehicle subscriptions. The self-drive rental business generates the majority of revenue. Geographically The company operates in India, Egypt, Indonesia, Vietnam, and the Philippines, Out of which the majority of revenue is derived from India.

About GLTO Galecto Inc.

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.

Share on Social Networks: